IP Library Granted Patent US 9,752,156
Granted Patent B2
US 9,752,156 · App. 14/840,019 · Granted Sep 5, 2017

Nucleic acid sequences encoding transcription factors regulating alkaloid biosynthesis and their use in modifying plant metabolism

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,752,156
App. No.
14/840,019
Granted
Sep 5, 2017
Kind
B2
Abstract

Plant metabolism and alkaloid levels can be regulated by transcription factors that regulate the nicotinic alkaloid biosynthetic pathway. In one embodiment, the disclosure provides a transcription factor that negatively regulates alkaloid biosynthesis, such as nicotine biosynthesis.

Claims (29)

1. An isolated cDNA molecule comprising a nucleotide sequence selected from the group consisting of:

(a) the nucleotide sequence set forth in SEQ ID NO: 8 or SEQ ID NO: 9;

(b) a nucleotide sequence that encodes a polypeptide having the amino acid sequence set forth in SEQ ID NO: 10; and

(c) a nucleotide sequence that is at least 90% identical to the nucleotide sequences of (a) or (b);

wherein (a), (b), and (c) encode a transcription factor that positively regulates nicotinic alkaloid biosynthesis.

2. A Nicotiana cell comprising the cDNA molecule of claim 1 .

3. The Nicotiana cell of claim 2 , wherein the level of the transcription factor in the Nicotiana cell is higher than in a Nicotiana cell that does not contain the nucleic acid molecule.

4. An expression vector comprising the nucleic acid molecule of claim 1 , operably linked to one or more control sequences suitable for directing expression in a Nicotiana cell.

5. A Nicotiana cell comprising the expression vector of claim 4 .

6. The Nicotiana cell of claim 5 , wherein the level of the transcription factor in the Nicotiana cell is higher than in a Nicotiana cell that does not contain the expression vector.

7. The isolated cDNA molecule of claim 1 , wherein the nucleotide sequence is set forth in SEQ ID NO: 8.

8. The isolated cDNA molecule of claim 1 , wherein the nucleotide sequence is set forth in SEQ ID NO: 9.

9. The isolated cDNA molecule of claim 1 , wherein the nucleotide sequence is at least 90% identical to the nucleotide sequence of SEQ ID NO: 8, and which encodes a transcription factor that positively regulates nicotinic alkaloid biosynthesis.

10. The isolated cDNA molecule of claim 1 , wherein the nucleotide sequence is at least 90% identical to the nucleotide sequence of SEQ ID NO: 9, and which encodes a transcription factor that positively regulates nicotinic alkaloid biosynthesis.

11. The isolated cDNA molecule of claim 1 , wherein the nucleotide sequence is at least 90% identical to the nucleotide sequence encoding a polypeptide having the amino acid sequence set forth in SEQ ID NO: 10, and which encodes a transcription factor that positively regulates nicotinic alkaloid biosynthesis.

12. A method for reducing a nicotinic alkaloid in a Nicotiana plant, comprising down-regulating a transcription factor that positively regulates nicotinic alkaloid biosynthesis, wherein the transcription factor is down-regulated by:

(a) genetically engineering a population of plant cells to eliminate production of a protein encoded by the nucleotide sequence set forth in SEQ ID NO: 8, comprising introducing one or more mutations into the region of SEQ ID NO: 8 that encodes a polypeptide having the amino acid sequence set forth in SEQ ID NO: 10; and

(b) detecting and selecting a target mutated plant cell or a plant derived from such a cell, wherein the target mutated plant cell or plant has a mutation in a gene encoding a transcription factor that positively regulates nicotinic alkaloid biosynthesis and wherein the targeted plant cell or plant has a decreased nicotinic alkaloid content relative to a control plant cell or plant.

13. The method of claim 12 , wherein the genetic engineering further comprises introducing into the population of cells a reagent comprising a recombinagenic oligonucleobase.

14. The method of claim 12 , wherein the genetic engineering further comprises introducing into the population of cells a reagent comprising a targeted nuclease.

15. The method of claim 12 , wherein the genetic engineering further comprises suppressing within the Nicotiana plant at least one of NBB1, A622, quinolate phospho-ribosyltransferase (QPT), putrescine-N-methyltransferase (PMT), and N-methylputrescine oxidase (MPO).

16. The method of claim 12 , wherein the genetic engineering further comprises suppressing within the Nicotiana plant at least one additional transcription factor that positively regulates nicotinic alkaloid biosynthesis.

17. The method of claim 12 , wherein the genetic engineering further comprises overexpressing within the Nicotiana plant at least one transcription factor that negatively regulates nicotinic alkaloid biosynthesis.

18. The method of claim 12 , wherein the genetic engineering further comprises introducing one or more mutations into regions of SEQ ID NO: 8 resulting in a complete deletion of the polypeptide having the amino acid sequence set forth in SEQ ID NO: 10.

19. A mutated Nicotiana plant produced by the method of claim 12 , wherein the plant has reduced expression of a transcription factor that positively regulates nicotinic alkaloid biosynthesis and reduced nicotinic alkaloid content, as compared to a control plant.

20. The mutated plant of claim 19 , wherein the plant is a Nicotiana tabacum plant.

21. A product having a reduced level of a nicotinic alkaloid comprising the mutated plant of claim 19 , or portions thereof, relative to a product produced from a control plant.

22. The product of claim 21 , wherein the product is selected from the group consisting of a cigarette, cigarette tobacco, cigar tobacco, a cigar, pipe tobacco, chewing tobacco, snuff, snus, lozenges, and reconstituted tobacco.

23. Seeds from the mutated plant of claim 19 .

Assignments (2)
PATENT SECURITY AGREEMENT Recorded Mar 29, 2023
From: 22ND CENTURY GROUP, INC.
To: JGB COLLATERAL, LLC
Reel/Frame 063188/0812 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2021
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: 22ND CENTURY LIMITED, LLC
Reel/Frame 055660/0188 →